SRZN (STOCKS)
Surrozen, Inc. Common
$29.860000
+1.660000 (+5.89%)
Prev close: $28.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Craig C. Parker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $344.49M
- Employees
- 41
- P/E (TTM)
- -0.80
- P/B (TTM)
- -1.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-8.36 | $-1.16 | -7.2023 | -622.12% |
|
Jun 2025 (Q2)
|
$2.55 | $-1.13 | +3.6822 | +325.23% |
|
Mar 2025 (Q1)
|
$-7.43 | $-1.82 | -5.6093 | -308.08% |
|
Dec 2024 (Q4)
|
$-9.10 | $-1.37 | -7.7332 | -565.79% |
Financial Statements
| Revenues | $3.48M |
| Benefits Costs and Expenses | $245.51M |
| Costs And Expenses | $245.51M |
| Operating Expenses | $45.57M |
| Depreciation and Amortization | $537.00K |
| Research and Development | $29.37M |
| Other Operating Expenses | $15.67M |
| Operating Income/Loss | -$42.09M |
| Income/Loss From Continuing Operations After Tax | -$242.03M |
| Income/Loss From Continuing Operations Before Tax | -$242.03M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$242.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$242.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$242.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$32.37 |
| Diluted Earnings Per Share | -$32.37 |
| Basic Average Shares | 7,478 |
| Diluted Average Shares | 7,478 |
| Assets | $98.73M |
| Current Assets | $91.56M |
| Noncurrent Assets | $7.17M |
| Fixed Assets | $433.00K |
| Other Non-current Assets | $6.73M |
| Liabilities | $286.49M |
| Current Liabilities | $9.93M |
| Accounts Payable | $728.00K |
| Other Current Liabilities | $9.20M |
| Noncurrent Liabilities | $276.56M |
| Equity | -$187.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$187.76M |
| Liabilities And Equity | $98.73M |
| Net Cash Flow From Operating Activities | -$30.24M |
| Net Cash Flow From Operating Activities, Continuing | -$30.24M |
| Net Cash Flow From Investing Activities | -$128.00K |
| Net Cash Flow From Investing Activities, Continuing | -$128.00K |
| Net Cash Flow From Financing Activities | $85.05M |
| Net Cash Flow From Financing Activities, Continuing | $85.05M |
| Net Cash Flow | $54.68M |
| Net Cash Flow, Continuing | $54.68M |
| Comprehensive Income/Loss | -$242.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$242.03M |
| Other Comprehensive Income/Loss | $0.00 |